Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France ; volume:11 ; number:1 ; day:25 ; month:6 ; year:2011 ; pages:1-10 ; date:12.2011
BMC health services research ; 11, Heft 1 (25.6.2011), 1-10, 12.2011
- Creator
-
Cotté, François-Emery
- Contributor
-
De Pouvourville, Gérard
SpringerLink (Online service)
- DOI
-
10.1186/1472-6963-11-151
- URN
-
urn:nbn:de:1111-2016072136273
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cotté, François-Emery
- De Pouvourville, Gérard
- SpringerLink (Online service)
Other Objects (12)
Quality of life in post-menopausal osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Association of LRP5 genotypes with osteoporosis in Tunisian post-menopausal women
Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
Postmenopausal osteoporosis
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Osteoporosis in urban post-menopausal women of the Philippines: prevalence and risk factors
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
A reappraisal of generic bisphosphonates in osteoporosis
Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis
Quality of life in post-menopausal osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Association of LRP5 genotypes with osteoporosis in Tunisian post-menopausal women
Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
Postmenopausal osteoporosis
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Osteoporosis in urban post-menopausal women of the Philippines: prevalence and risk factors
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
A reappraisal of generic bisphosphonates in osteoporosis
Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis
Quality of life in post-menopausal osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Association of LRP5 genotypes with osteoporosis in Tunisian post-menopausal women
Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
Postmenopausal osteoporosis
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Osteoporosis in urban post-menopausal women of the Philippines: prevalence and risk factors
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
A reappraisal of generic bisphosphonates in osteoporosis
Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates